A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 2 Sponsors

No summary has been published for this bill. The full text is on the Bill text tab.

Chamber: Senate
Introduced: Jul 21, 2026
Last action: Jul 21, 2026 — Introduced in Senate
Session: 119
Momentum: 21 · Low

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Introduced — base rate 2%, measured from US's completed sessions
Momentum -6 21/100 from the pace of recorded action
Time since last action -9 82 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.